

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle tissue regeneration (GO:0043403) | 9.85575704 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 9.23072261 |
| 3 | response to muscle activity (GO:0014850) | 8.91403331 |
| 4 | negative regulation of skeletal muscle tissue development (GO:0048642) | 8.32469396 |
| 5 | actin-mediated cell contraction (GO:0070252) | 8.20640552 |
| 6 | cellular response to dexamethasone stimulus (GO:0071549) | 6.79574262 |
| 7 | response to activity (GO:0014823) | 6.38798346 |
| 8 | response to dexamethasone (GO:0071548) | 6.28989943 |
| 9 | actin filament-based movement (GO:0030048) | 5.77143782 |
| 10 | striated muscle adaptation (GO:0014888) | 5.46591932 |
| 11 | negative regulation of organelle assembly (GO:1902116) | 4.73106530 |
| 12 | protein K6-linked ubiquitination (GO:0085020) | 4.67893585 |
| 13 | regulation of muscle hypertrophy (GO:0014743) | 4.46996111 |
| 14 | protein trimerization (GO:0070206) | 4.46512418 |
| 15 | muscle adaptation (GO:0043500) | 4.36814191 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.29881488 |
| 17 | skeletal muscle contraction (GO:0003009) | 4.27896128 |
| 18 | response to testosterone (GO:0033574) | 4.20117095 |
| 19 | negative regulation of striated muscle tissue development (GO:0045843) | 4.12973601 |
| 20 | myotube cell development (GO:0014904) | 4.12669265 |
| 21 | response to electrical stimulus (GO:0051602) | 4.10877344 |
| 22 | motile cilium assembly (GO:0044458) | 4.08396671 |
| 23 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.05993161 |
| 24 | negative regulation of muscle tissue development (GO:1901862) | 4.05202597 |
| 25 | dosage compensation (GO:0007549) | 4.05023908 |
| 26 | regulation of DNA methylation (GO:0044030) | 4.03415730 |
| 27 | protein polyglutamylation (GO:0018095) | 4.01169039 |
| 28 | muscle organ development (GO:0007517) | 3.96648632 |
| 29 | muscle structure development (GO:0061061) | 3.88228518 |
| 30 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.87105058 |
| 31 | negative regulation of muscle organ development (GO:0048635) | 3.86625197 |
| 32 | tissue regeneration (GO:0042246) | 3.73379202 |
| 33 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.67239842 |
| 34 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.66971450 |
| 35 | skeletal muscle fiber development (GO:0048741) | 3.58953523 |
| 36 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.57566272 |
| 37 | genetic imprinting (GO:0071514) | 3.52380304 |
| 38 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.51289558 |
| 39 | response to inactivity (GO:0014854) | 3.42232329 |
| 40 | cellular response to ketone (GO:1901655) | 3.39385867 |
| 41 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.35331160 |
| 42 | viral transcription (GO:0019083) | 3.29027048 |
| 43 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.27950006 |
| 44 | cellular response to corticosteroid stimulus (GO:0071384) | 3.26654745 |
| 45 | heparin metabolic process (GO:0030202) | 3.25153310 |
| 46 | heparin biosynthetic process (GO:0030210) | 3.25153310 |
| 47 | muscle system process (GO:0003012) | 3.22433452 |
| 48 | regulation of relaxation of muscle (GO:1901077) | 3.19145772 |
| 49 | muscle contraction (GO:0006936) | 3.14721641 |
| 50 | translational termination (GO:0006415) | 3.09411922 |
| 51 | cell proliferation in forebrain (GO:0021846) | 3.08353883 |
| 52 | regulation of centriole replication (GO:0046599) | 3.07145494 |
| 53 | ribosomal small subunit assembly (GO:0000028) | 2.97351264 |
| 54 | translational elongation (GO:0006414) | 2.97193976 |
| 55 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.97064013 |
| 56 | behavioral response to nicotine (GO:0035095) | 2.92342725 |
| 57 | maturation of SSU-rRNA (GO:0030490) | 2.83191952 |
| 58 | regulation of histone H3-K9 methylation (GO:0051570) | 2.80235141 |
| 59 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.80086267 |
| 60 | calcium ion import (GO:0070509) | 2.74766809 |
| 61 | dendritic spine morphogenesis (GO:0060997) | 2.74367887 |
| 62 | secondary heart field specification (GO:0003139) | 2.72699129 |
| 63 | heart field specification (GO:0003128) | 2.72699129 |
| 64 | regulation of female gonad development (GO:2000194) | 2.68000234 |
| 65 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.65604771 |
| 66 | ribosomal small subunit biogenesis (GO:0042274) | 2.63293059 |
| 67 | negative regulation of histone methylation (GO:0031061) | 2.60741357 |
| 68 | viral genome replication (GO:0019079) | 2.59880160 |
| 69 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.59702077 |
| 70 | negative regulation of histone acetylation (GO:0035067) | 2.59544435 |
| 71 | pattern specification involved in kidney development (GO:0061004) | 2.58818727 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 2.58367237 |
| 73 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.57185102 |
| 74 | muscle fiber development (GO:0048747) | 2.56870050 |
| 75 | striated muscle contraction (GO:0006941) | 2.56410777 |
| 76 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.55324071 |
| 77 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50727207 |
| 78 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.50476222 |
| 79 | middle ear morphogenesis (GO:0042474) | 2.48919585 |
| 80 | nephron epithelium morphogenesis (GO:0072088) | 2.46593241 |
| 81 | nephron tubule morphogenesis (GO:0072078) | 2.46593241 |
| 82 | myoblast migration (GO:0051451) | 2.46157640 |
| 83 | negative regulation of developmental growth (GO:0048640) | 2.44886442 |
| 84 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.44409910 |
| 85 | regulation of synapse structural plasticity (GO:0051823) | 2.43467274 |
| 86 | somite development (GO:0061053) | 2.39342119 |
| 87 | sarcomere organization (GO:0045214) | 2.37911083 |
| 88 | axoneme assembly (GO:0035082) | 2.34964704 |
| 89 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.34714006 |
| 90 | mesonephros development (GO:0001823) | 2.33462821 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.31915461 |
| 92 | protein targeting to ER (GO:0045047) | 2.31795828 |
| 93 | cartilage morphogenesis (GO:0060536) | 2.31455300 |
| 94 | response to gravity (GO:0009629) | 15.3344472 |
| 95 | skeletal muscle adaptation (GO:0043501) | 12.8615571 |
| 96 | striated muscle atrophy (GO:0014891) | 12.7068752 |
| 97 | muscle atrophy (GO:0014889) | 11.3137057 |
| 98 | negative regulation of muscle hypertrophy (GO:0014741) | 11.1967213 |
| 99 | actin-myosin filament sliding (GO:0033275) | 10.0591408 |
| 100 | muscle filament sliding (GO:0030049) | 10.0591408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 7.71516578 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.37390792 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.43938826 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.14853181 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.90762538 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.44945294 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.37207480 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.26598321 |
| 9 | FUS_26573619_Chip-Seq_HEK293_Human | 2.64094804 |
| 10 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.49547848 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48841060 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42771161 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40255635 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26744286 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22795764 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05988168 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00194787 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97974514 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.90471246 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85454653 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85422521 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72440681 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72223451 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.70567468 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67420276 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65965341 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.65577610 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64247023 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.63527993 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61724139 |
| 31 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.59186474 |
| 32 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.57533777 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57254736 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55069302 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.53600613 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.53600613 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50842069 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48886551 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47855889 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47191081 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45703845 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44270990 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43311397 |
| 44 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.42459160 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38643281 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37997002 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36642872 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36087736 |
| 49 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.35722572 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33249539 |
| 51 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26052438 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25201174 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25126858 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18462885 |
| 55 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.13412593 |
| 56 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12701709 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12122389 |
| 58 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05486746 |
| 59 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.05211310 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03099385 |
| 61 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.02734832 |
| 62 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00033955 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97052461 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97004891 |
| 65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96180202 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96109103 |
| 67 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94996596 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93803918 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93476782 |
| 70 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.92271423 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91817930 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90688075 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89511745 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89354127 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87519193 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87060297 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85418488 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84453493 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84453493 |
| 80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.83698238 |
| 81 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83346120 |
| 82 | NCOR_22424771_ChIP-Seq_293T_Human | 0.80791017 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80162444 |
| 84 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79985136 |
| 85 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.78597003 |
| 86 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78502744 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.76749961 |
| 88 | ERA_21632823_ChIP-Seq_H3396_Human | 0.75698929 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74398906 |
| 90 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.74263027 |
| 91 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.73980962 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73819180 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73688799 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73630986 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73016402 |
| 96 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.71993815 |
| 97 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.71301613 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.71125535 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.71103744 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.69860685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.75171089 |
| 2 | MP0000747_muscle_weakness | 5.29411299 |
| 3 | MP0002089_abnormal_postnatal_growth/wei | 4.30495176 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.72981396 |
| 5 | MP0000749_muscle_degeneration | 3.49652831 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.48053089 |
| 7 | MP0002269_muscular_atrophy | 3.38005867 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.15587700 |
| 9 | MP0002108_abnormal_muscle_morphology | 2.77058130 |
| 10 | MP0003787_abnormal_imprinting | 2.71721311 |
| 11 | MP0003646_muscle_fatigue | 2.71467067 |
| 12 | MP0002638_abnormal_pupillary_reflex | 2.70778894 |
| 13 | MP0005083_abnormal_biliary_tract | 2.56711624 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.53931845 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.53175873 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.52136720 |
| 17 | MP0003959_abnormal_lean_body | 2.26895352 |
| 18 | MP0004142_abnormal_muscle_tone | 2.08572105 |
| 19 | MP0005369_muscle_phenotype | 2.00372932 |
| 20 | MP0003123_paternal_imprinting | 1.81599361 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.80692659 |
| 22 | MP0000566_synostosis | 1.80228878 |
| 23 | MP0000750_abnormal_muscle_regeneration | 1.79859994 |
| 24 | MP0000751_myopathy | 1.78354336 |
| 25 | MP0002736_abnormal_nociception_after | 1.68716739 |
| 26 | MP0004270_analgesia | 1.65945685 |
| 27 | MP0000733_abnormal_muscle_development | 1.58234174 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.50534298 |
| 29 | MP0000778_abnormal_nervous_system | 1.43506101 |
| 30 | MP0003937_abnormal_limbs/digits/tail_de | 1.42778806 |
| 31 | MP0004130_abnormal_muscle_cell | 1.39335883 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.39282047 |
| 33 | MP0004885_abnormal_endolymph | 1.38927412 |
| 34 | MP0000427_abnormal_hair_cycle | 1.37515505 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.37218349 |
| 36 | MP0000049_abnormal_middle_ear | 1.36417460 |
| 37 | MP0003121_genomic_imprinting | 1.29909575 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.28744133 |
| 39 | MP0002102_abnormal_ear_morphology | 1.28214734 |
| 40 | MP0002095_abnormal_skin_pigmentation | 1.25162784 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.20210012 |
| 42 | MP0003880_abnormal_central_pattern | 1.16296890 |
| 43 | MP0009250_abnormal_appendicular_skeleto | 1.13244605 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.12232707 |
| 45 | MP0004043_abnormal_pH_regulation | 1.12095729 |
| 46 | MP0003786_premature_aging | 1.12067386 |
| 47 | MP0003122_maternal_imprinting | 1.07281719 |
| 48 | MP0003045_fibrosis | 1.06451925 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.04105081 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.04075790 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.01960705 |
| 52 | MP0003938_abnormal_ear_development | 1.01795566 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 0.97445843 |
| 54 | MP0002272_abnormal_nervous_system | 0.94865585 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 0.94301164 |
| 56 | MP0005257_abnormal_intraocular_pressure | 0.93853324 |
| 57 | MP0009745_abnormal_behavioral_response | 0.92078721 |
| 58 | MP0002067_abnormal_sensory_capabilities | 0.88009694 |
| 59 | MP0002733_abnormal_thermal_nociception | 0.87537046 |
| 60 | MP0001348_abnormal_lacrimal_gland | 0.84368556 |
| 61 | MP0008872_abnormal_physiological_respon | 0.83493267 |
| 62 | MP0005423_abnormal_somatic_nervous | 0.81410464 |
| 63 | MP0000467_abnormal_esophagus_morphology | 0.81357609 |
| 64 | MP0001502_abnormal_circadian_rhythm | 0.78560565 |
| 65 | MP0004742_abnormal_vestibular_system | 0.78376709 |
| 66 | MP0002184_abnormal_innervation | 0.75381502 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 0.74691861 |
| 68 | MP0001486_abnormal_startle_reflex | 0.72647947 |
| 69 | MP0004484_altered_response_of | 0.69960648 |
| 70 | MP0002109_abnormal_limb_morphology | 0.69444471 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 0.68653822 |
| 72 | MP0004084_abnormal_cardiac_muscle | 0.68146828 |
| 73 | MP0002557_abnormal_social/conspecific_i | 0.68027444 |
| 74 | MP0005452_abnormal_adipose_tissue | 0.67482035 |
| 75 | MP0002114_abnormal_axial_skeleton | 0.67151298 |
| 76 | MP0001485_abnormal_pinna_reflex | 0.66685184 |
| 77 | MP0008770_decreased_survivor_rate | 0.65379259 |
| 78 | MP0004134_abnormal_chest_morphology | 0.65144701 |
| 79 | MP0003119_abnormal_digestive_system | 0.63555010 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63121595 |
| 81 | MP0001970_abnormal_pain_threshold | 0.62532417 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.62193651 |
| 83 | MP0003950_abnormal_plasma_membrane | 0.62119320 |
| 84 | MP0003755_abnormal_palate_morphology | 0.62108900 |
| 85 | MP0000955_abnormal_spinal_cord | 0.61611559 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.61243184 |
| 87 | MP0002115_abnormal_skeleton_extremities | 0.60768157 |
| 88 | MP0004147_increased_porphyrin_level | 0.60361167 |
| 89 | MP0001661_extended_life_span | 0.60142498 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.59005075 |
| 91 | MP0003936_abnormal_reproductive_system | 0.58783511 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.58734009 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.58722653 |
| 94 | MP0000537_abnormal_urethra_morphology | 0.58345154 |
| 95 | MP0002116_abnormal_craniofacial_bone | 0.58244403 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.57462970 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.54194882 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.53283073 |
| 99 | MP0001984_abnormal_olfaction | 0.53186969 |
| 100 | MP0003942_abnormal_urinary_system | 0.52536779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 9.23509851 |
| 2 | Distal arthrogryposis (HP:0005684) | 7.60940407 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.75261032 |
| 4 | Round ear (HP:0100830) | 6.68324819 |
| 5 | Mask-like facies (HP:0000298) | 6.62480370 |
| 6 | Nemaline bodies (HP:0003798) | 6.51056301 |
| 7 | Absent phalangeal crease (HP:0006109) | 5.97383623 |
| 8 | Ulnar deviation of the wrist (HP:0003049) | 5.95603880 |
| 9 | Calcaneovalgus deformity (HP:0001848) | 5.82214456 |
| 10 | Deformed tarsal bones (HP:0008119) | 5.45457478 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 5.28560625 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.16966981 |
| 13 | Abnormal finger flexion creases (HP:0006143) | 5.04684442 |
| 14 | Hyperkalemia (HP:0002153) | 4.89874318 |
| 15 | Periorbital edema (HP:0100539) | 4.60964731 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 4.54348335 |
| 17 | Facial edema (HP:0000282) | 4.44588486 |
| 18 | Myopathic facies (HP:0002058) | 4.01002901 |
| 19 | Myotonia (HP:0002486) | 3.57161677 |
| 20 | Myoglobinuria (HP:0002913) | 3.29764435 |
| 21 | Abnormality of potassium homeostasis (HP:0011042) | 3.19464186 |
| 22 | Exercise-induced muscle cramps (HP:0003710) | 3.14339693 |
| 23 | Abnormality of the calcaneus (HP:0008364) | 2.97342566 |
| 24 | Decreased circulating renin level (HP:0003351) | 2.93197735 |
| 25 | Neoplasm of the heart (HP:0100544) | 2.88285561 |
| 26 | Hyperphosphatemia (HP:0002905) | 2.85255977 |
| 27 | Nonprogressive disorder (HP:0003680) | 2.84208289 |
| 28 | Oligomenorrhea (HP:0000876) | 2.80250648 |
| 29 | Increased connective tissue (HP:0009025) | 2.79491051 |
| 30 | Metatarsus adductus (HP:0001840) | 2.69597081 |
| 31 | Down-sloping shoulders (HP:0200021) | 2.69381341 |
| 32 | Difficulty running (HP:0009046) | 2.68631389 |
| 33 | Reticulocytopenia (HP:0001896) | 2.65023581 |
| 34 | Muscle stiffness (HP:0003552) | 2.52454592 |
| 35 | Malignant hyperthermia (HP:0002047) | 2.41499246 |
| 36 | Stenosis of the external auditory canal (HP:0000402) | 2.41319038 |
| 37 | Congenital stationary night blindness (HP:0007642) | 2.39913982 |
| 38 | Fibular aplasia (HP:0002990) | 2.39243691 |
| 39 | Rectal prolapse (HP:0002035) | 2.38835457 |
| 40 | Microglossia (HP:0000171) | 2.33597459 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.32967241 |
| 42 | Hypokalemia (HP:0002900) | 2.28540507 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.17003848 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.05339370 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.05339370 |
| 46 | Abnormality of chloride homeostasis (HP:0011422) | 2.01893342 |
| 47 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.01190626 |
| 48 | Tarsal synostosis (HP:0008368) | 1.99697753 |
| 49 | Colon cancer (HP:0003003) | 1.98518222 |
| 50 | Mesomelia (HP:0003027) | 1.98364085 |
| 51 | Abnormality of the peritoneum (HP:0002585) | 1.94525096 |
| 52 | Pancreatic fibrosis (HP:0100732) | 1.91580277 |
| 53 | Polydipsia (HP:0001959) | 1.90939316 |
| 54 | Abnormal drinking behavior (HP:0030082) | 1.90939316 |
| 55 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90761470 |
| 56 | Abnormality of the parietal bone (HP:0002696) | 1.90716268 |
| 57 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.88257506 |
| 58 | Short 4th metacarpal (HP:0010044) | 1.88257506 |
| 59 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.87979676 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.86084052 |
| 61 | Nephronophthisis (HP:0000090) | 1.85709638 |
| 62 | Abnormality of the nasal septum (HP:0000419) | 1.83975388 |
| 63 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.83550915 |
| 64 | Synostosis involving bones of the feet (HP:0009140) | 1.83550915 |
| 65 | Supernumerary ribs (HP:0005815) | 1.82894094 |
| 66 | Bell-shaped thorax (HP:0001591) | 1.77686483 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76810316 |
| 68 | Lip pit (HP:0100267) | 1.74830660 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 1.74503489 |
| 70 | Abnormality of the columella (HP:0009929) | 1.74107942 |
| 71 | Abnormality of the 4th metacarpal (HP:0010012) | 1.73342933 |
| 72 | Paralysis (HP:0003470) | 1.72179706 |
| 73 | Menstrual irregularities (HP:0000858) | 1.72069550 |
| 74 | Broad-based gait (HP:0002136) | 1.72026916 |
| 75 | Hypoplastic iliac wings (HP:0002866) | 1.71431414 |
| 76 | Maternal diabetes (HP:0009800) | 1.70960518 |
| 77 | Asplenia (HP:0001746) | 1.70284758 |
| 78 | 2-3 toe syndactyly (HP:0004691) | 1.69881747 |
| 79 | Anencephaly (HP:0002323) | 1.69526966 |
| 80 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.68218077 |
| 81 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.63431946 |
| 82 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62062708 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 1.62033566 |
| 84 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.60755982 |
| 85 | Abnormality of incisor morphology (HP:0011063) | 1.56809221 |
| 86 | Generalized muscle weakness (HP:0003324) | 1.56535593 |
| 87 | Acute necrotizing encephalopathy (HP:0006965) | 1.56026369 |
| 88 | Decreased subcutaneous fat (HP:0001002) | 1.55827097 |
| 89 | Short phalanx of the thumb (HP:0009660) | 1.55261819 |
| 90 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.54470790 |
| 91 | Abnormality of the renal collecting system (HP:0004742) | 1.51244634 |
| 92 | Hypoplastic ischia (HP:0003175) | 1.50888763 |
| 93 | Intellectual disability, moderate (HP:0002342) | 1.48219014 |
| 94 | Bile duct proliferation (HP:0001408) | 1.48156559 |
| 95 | Abnormal biliary tract physiology (HP:0012439) | 1.48156559 |
| 96 | Hyperaldosteronism (HP:0000859) | 1.47397054 |
| 97 | Wrist flexion contracture (HP:0001239) | 1.47059444 |
| 98 | Pendular nystagmus (HP:0012043) | 1.46566348 |
| 99 | Ulnar deviation of finger (HP:0009465) | 1.46360995 |
| 100 | Pancreatic cysts (HP:0001737) | 1.45112503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 4.78267842 |
| 2 | PHKG1 | 4.78267842 |
| 3 | TIE1 | 4.45715541 |
| 4 | OBSCN | 4.42602323 |
| 5 | WNK4 | 3.94905824 |
| 6 | PINK1 | 3.01515779 |
| 7 | TYRO3 | 2.84674377 |
| 8 | PIK3CA | 2.68580424 |
| 9 | CAMKK2 | 2.45365979 |
| 10 | CAMK1D | 2.44703183 |
| 11 | WNK1 | 2.30858277 |
| 12 | LIMK1 | 2.02735361 |
| 13 | NUAK1 | 2.00735331 |
| 14 | MAPK13 | 1.84780772 |
| 15 | CAMK1G | 1.74584112 |
| 16 | JAK3 | 1.73600950 |
| 17 | MAP4K2 | 1.67983814 |
| 18 | CASK | 1.60838125 |
| 19 | MAP3K11 | 1.53607796 |
| 20 | BCKDK | 1.50628587 |
| 21 | ADRBK2 | 1.42103841 |
| 22 | PIK3CG | 1.36055610 |
| 23 | MUSK | 1.30911828 |
| 24 | DYRK1B | 1.30275113 |
| 25 | CHEK2 | 1.28517937 |
| 26 | NME2 | 1.20161307 |
| 27 | STK39 | 1.19499042 |
| 28 | TLK1 | 1.18080707 |
| 29 | TXK | 1.17565015 |
| 30 | CAMKK1 | 1.14775880 |
| 31 | AURKA | 1.13738283 |
| 32 | DMPK | 1.06770025 |
| 33 | EPHB2 | 1.06740135 |
| 34 | CDK4 | 1.05958321 |
| 35 | CAMK1 | 1.05621383 |
| 36 | CAMK2G | 1.04787023 |
| 37 | IRAK1 | 1.01224642 |
| 38 | CSNK1G2 | 0.98180260 |
| 39 | DAPK2 | 0.97911660 |
| 40 | GRK1 | 0.88876151 |
| 41 | CAMK4 | 0.84583271 |
| 42 | DYRK2 | 0.83453927 |
| 43 | DDR2 | 0.77849848 |
| 44 | MARK3 | 0.76730470 |
| 45 | CSNK1G1 | 0.76212841 |
| 46 | CSNK1A1L | 0.76168444 |
| 47 | TEC | 0.70680487 |
| 48 | MAP2K2 | 0.70104930 |
| 49 | ZAK | 0.67657786 |
| 50 | OXSR1 | 0.65799899 |
| 51 | MAP3K4 | 0.65375248 |
| 52 | SGK1 | 0.64808197 |
| 53 | EPHA4 | 0.64521629 |
| 54 | TAOK3 | 0.62471224 |
| 55 | MAP2K7 | 0.62351053 |
| 56 | MAP3K12 | 0.60577878 |
| 57 | TNIK | 0.60282990 |
| 58 | CSNK1G3 | 0.58857359 |
| 59 | SGK494 | 0.58850189 |
| 60 | SGK223 | 0.58850189 |
| 61 | FRK | 0.57994501 |
| 62 | SGK3 | 0.57409115 |
| 63 | TAF1 | 0.57192553 |
| 64 | MAPK7 | 0.56504993 |
| 65 | PRKG1 | 0.51960742 |
| 66 | MAPK12 | 0.50648359 |
| 67 | RPS6KA5 | 0.48568707 |
| 68 | PRKACA | 0.47237889 |
| 69 | TESK1 | 0.47015768 |
| 70 | VRK2 | 0.46739423 |
| 71 | STK11 | 0.43594282 |
| 72 | NTRK2 | 0.41719996 |
| 73 | STK16 | 0.40413336 |
| 74 | PRKCQ | 0.40250085 |
| 75 | ILK | 0.39146044 |
| 76 | CCNB1 | 0.38764489 |
| 77 | PIM1 | 0.38716383 |
| 78 | RPS6KA3 | 0.37187372 |
| 79 | VRK1 | 0.36304823 |
| 80 | RPS6KA6 | 0.36180395 |
| 81 | SGK2 | 0.34810270 |
| 82 | TRPM7 | 0.32696517 |
| 83 | PRKAA2 | 0.32524114 |
| 84 | MINK1 | 0.31529086 |
| 85 | PRKCG | 0.30955830 |
| 86 | PRKACB | 0.28705757 |
| 87 | MAP3K7 | 0.27362096 |
| 88 | PRKCA | 0.27267780 |
| 89 | PRKCH | 0.26320196 |
| 90 | CDK19 | 0.26227967 |
| 91 | ITK | 0.26115137 |
| 92 | RPS6KC1 | 0.25183356 |
| 93 | RPS6KL1 | 0.25183356 |
| 94 | FGFR2 | 0.24676610 |
| 95 | ABL2 | 0.24501031 |
| 96 | DYRK3 | 0.23573949 |
| 97 | GRK7 | 0.22282289 |
| 98 | PRKD2 | 0.21776449 |
| 99 | PRKD3 | 0.20094313 |
| 100 | ADRBK1 | 0.19416527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.46725463 |
| 2 | Tight junction_Homo sapiens_hsa04530 | 3.92331601 |
| 3 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.97700701 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.80105934 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.45195315 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.40239298 |
| 7 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.33718654 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98005606 |
| 9 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.94067619 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.87060388 |
| 11 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.83159531 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.76859307 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.70500933 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66165485 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.62898406 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62580890 |
| 17 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.58024706 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.57456908 |
| 19 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.54915576 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52657657 |
| 21 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.43865089 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40088564 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39823747 |
| 24 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.39492693 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36378171 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.35242942 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.33663729 |
| 28 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.33201817 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.30382538 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.21221748 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20681120 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19527872 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.18189809 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17372868 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.17103490 |
| 36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14260143 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11316346 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.08035383 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06603791 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06456554 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05879875 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05598605 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05390664 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.04013233 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.00742188 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 0.98512386 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96448165 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 0.94992938 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.92350628 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.91784757 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90589697 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89306518 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83908874 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.82921446 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.82421420 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81265398 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79831019 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77688900 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75644015 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75565327 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73868455 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73709453 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72738732 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72583396 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72570496 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71179083 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64525874 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60721901 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.60483172 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60271034 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60239774 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60128289 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60008038 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58504223 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.57841765 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57838988 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.55591598 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.55340285 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.54718933 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54055424 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47073666 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45084598 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43060175 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42469494 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41436483 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38774977 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37885567 |
| 88 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37769412 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36610999 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36288569 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35535460 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35530395 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35501044 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34009584 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33677430 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.32410747 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31972141 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30471307 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28751173 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28413172 |

